Article
Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
mSphere - 20 Jan 2021
Oakley Juliette L, Weiser Rebecca, Powell Lydia C, Forton Julian, Mahenthiralingam Eshwar, Rye Philip D, Hill Katja E, Thomas David W, Pritchard Manon F
Abstract excerpt
Chronic Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) evolve to generate environmentally adapted biofilm communities, leading to increased patient morbidity and mortality. OligoG CF-5/20, a low-molecular-weight inhaled alginate oligomer therapy, is currently in phase IIb/III clinical trials in CF patients. Experimental evolution of P. aeruginosa in response to OligoG CF-5/20 was assessed using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
